Literature DB >> 29739763

Iatrogenic immunosuppression may favour Alternaria skin lesion flares.

Rosanna Satta1, Maria Pina Dore1, Giovanni Mario Pes1, Gabriele Biondi1.   

Abstract

Alternaria spp may cause opportunistic mycoses in the skin after cutaneous inoculation or through blood dissemination in immune-suppressed patients. Here, we describe a case of cutaneous infection with Alternaria spp in a 62-year-old man, presenting with multifocal papules and erythematous nodules involving distal limbs bilaterally. The absence of inflammatory bowel disease was confirmed by a gastroenterologist. The patient was under treatment for uveitis of unknown origin with immunosuppressive doses of cyclosporin and prednisolone for approximately 3 months. The diagnosis was based on clinical signs, demonstration of fungal elements in skin biopsies and deep fungal culture. Complete clinical remission was achieved by oral and systemic treatment with antifungal drugs. However, because cessation of the immunosuppressive medication was not possible, his clinical history was characterised by multiple flares requiring each time oral and intravenous antifungal treatment. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  dermatology; infectious diseases

Mesh:

Substances:

Year:  2018        PMID: 29739763      PMCID: PMC5950624          DOI: 10.1136/bcr-2017-223857

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Cutaneous alternariosis microscopically mimicking blastomycosis.

Authors:  Gregory W Osmond; Robert W Walters; Puja K Puri
Journal:  J Cutan Pathol       Date:  2011-07-14       Impact factor: 1.587

2.  Phaeohyphomycosis in transplant recipients: Results from the Transplant Associated Infection Surveillance Network (TRANSNET).

Authors:  Todd P McCarty; John W Baddley; Thomas J Walsh; Barbara D Alexander; Dimitrios P Kontoyiannis; Trish M Perl; Randall Walker; Thomas F Patterson; Mindy G Schuster; G Marshall Lyon; John R Wingard; David R Andes; Benjamin J Park; Mary E Brandt; Peter G Pappas
Journal:  Med Mycol       Date:  2015-04-23       Impact factor: 4.076

3.  Cutaneous alternariosis in transplant recipients: clinicopathologic review of 9 cases.

Authors:  Montserrat Gilaberte; Ramón Bartralot; Josep M Torres; Ferran Sánchez Reus; Virginia Rodríguez; Agustín Alomar; Ramón M Pujol
Journal:  J Am Acad Dermatol       Date:  2005-04       Impact factor: 11.527

4.  First case of disseminated phaeohyphomycosis in an immunocompetent individual due to Alternaria malorum.

Authors:  Hossein Mirhendi; Mohammad Javad Fatemi; Hamid Bateni; Mahboubeh Hajabdolbaghi; Mohsen Geramishoar; Bahram Ahmadi; Hamid Badali
Journal:  Med Mycol       Date:  2012-08-08       Impact factor: 4.076

5.  Subcutaneous phaeohyphomycosis (mycotic cyst).

Authors:  Rafael Isa-Isa; Carlos García; Mariel Isa; Roberto Arenas
Journal:  Clin Dermatol       Date:  2012 Jul-Aug       Impact factor: 3.541

6.  Cutaneous Alternaria infectoria infection diagnosed by molecular techniques in a renal transplant patient.

Authors:  Duygu Daglar; Ayse Akman-Karakas; Betil Ozhak-Baysan; Filiz Gunseren; Mehmet Akif Ciftcioglu; Maria José Buitrago; Juan Luis Rodriguez-Tudela
Journal:  Clin Lab       Date:  2014       Impact factor: 1.138

Review 7.  Alternaria arborescens infection in a healthy individual and literature review of cutaneous alternariosis.

Authors:  Wenying Hu; Yuping Ran; Kaiwen Zhuang; Jebina Lama; Chaoliang Zhang
Journal:  Mycopathologia       Date:  2014-10-14       Impact factor: 2.574

Review 8.  Alternaria infections: laboratory diagnosis and relevant clinical features.

Authors:  F J Pastor; J Guarro
Journal:  Clin Microbiol Infect       Date:  2008-08       Impact factor: 8.067

9.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.

Authors:  A Chowdhary; J F Meis; J Guarro; G S de Hoog; S Kathuria; M C Arendrup; S Arikan-Akdagli; M Akova; T Boekhout; M Caira; J Guinea; A Chakrabarti; E Dannaoui; A van Diepeningen; T Freiberger; A H Groll; W W Hope; E Johnson; M Lackner; K Lagrou; F Lanternier; C Lass-Flörl; O Lortholary; J Meletiadis; P Muñoz; L Pagano; G Petrikkos; M D Richardson; E Roilides; A Skiada; A M Tortorano; A J Ullmann; P E Verweij; O A Cornely; M Cuenca-Estrella
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.